Skip to main content
PMC home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1998;25(4):238–250.

Outpatient management of congestive heart failure.

E K Massin 1
PMCID: PMC325567  PMID: 9885099

Full text

PDF
238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham W. T., Lowes B. D., Ferguson D. A., Odom J., Kim J. K., Robertson A. D., Bristow M. R., Schrier R. W. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail. 1998 Mar;4(1):37–44. doi: 10.1016/s1071-9164(98)90506-1. [DOI] [PubMed] [Google Scholar]
  2. Al-Khadra A. S., Salem D. N., Rand W. M., Udelson J. E., Smith J. J., Konstam M. A. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. J Am Coll Cardiol. 1998 Feb;31(2):419–425. doi: 10.1016/s0735-1097(97)00502-0. [DOI] [PubMed] [Google Scholar]
  3. Al-Khadra A. S., Salem D. N., Rand W. M., Udelson J. E., Smith J. J., Konstam M. A. Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998 Mar 15;31(4):749–753. doi: 10.1016/s0735-1097(98)00006-0. [DOI] [PubMed] [Google Scholar]
  4. Anand I. S., Kalra G. S., Ferrari R., Harris P., Poole-Wilson P. A. Hemodynamic, hormonal, and renal effects of atrial natriuretic peptide in untreated congestive cardiac failure. Am Heart J. 1989 Sep;118(3):500–505. doi: 10.1016/0002-8703(89)90264-0. [DOI] [PubMed] [Google Scholar]
  5. Barjon J. N., Rouleau J. L., Bichet D., Juneau C., De Champlain J. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol. 1987 Mar;9(3):622–630. doi: 10.1016/s0735-1097(87)80057-8. [DOI] [PubMed] [Google Scholar]
  6. Brater D. C. Diuretic therapy. N Engl J Med. 1998 Aug 6;339(6):387–395. doi: 10.1056/NEJM199808063390607. [DOI] [PubMed] [Google Scholar]
  7. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  8. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  10. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  11. Cohn J. N., Mathew K. J., Franciosa J. A., Snow J. A. Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. Ann Intern Med. 1974 Dec;81(6):777–780. doi: 10.7326/0003-4819-81-6-777. [DOI] [PubMed] [Google Scholar]
  12. Cohn J. N., Ziesche S., Smith R., Anand I., Dunkman W. B., Loeb H., Cintron G., Boden W., Baruch L., Rochin P. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation. 1997 Aug 5;96(3):856–863. doi: 10.1161/01.cir.96.3.856. [DOI] [PubMed] [Google Scholar]
  13. Crozier I. G., Nicholls M. G., Ikram H., Espiner E. A., Gomez H. J., Warner N. J. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet. 1986 Nov 29;2(8518):1242–1245. doi: 10.1016/s0140-6736(86)92675-9. [DOI] [PubMed] [Google Scholar]
  14. Currie P. J., Kelly M. J., McKenzie A., Harper R. W., Lim Y. L., Federman J., Anderson S. T., Pitt A. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol. 1984 Jan;3(1):203–209. doi: 10.1016/s0735-1097(84)80449-0. [DOI] [PubMed] [Google Scholar]
  15. DiBianco R. Adverse reactions with angiotensin converting enzyme (ACE) inhibitors. Med Toxicol. 1986 Mar-Apr;1(2):122–141. doi: 10.1007/BF03259832. [DOI] [PubMed] [Google Scholar]
  16. Dikshit K., Vyden J. K., Forrester J. S., Chatterjee K., Prakash R., Swan H. J. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med. 1973 May 24;288(21):1087–1090. doi: 10.1056/NEJM197305242882102. [DOI] [PubMed] [Google Scholar]
  17. Dries D. L., Rosenberg Y. D., Waclawiw M. A., Domanski M. J. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997 Apr;29(5):1074–1080. doi: 10.1016/s0735-1097(97)00019-3. [DOI] [PubMed] [Google Scholar]
  18. Eichhorn E. J., Bedotto J. B., Malloy C. R., Hatfield B. A., Deitchman D., Brown M., Willard J. E., Grayburn P. A. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation. 1990 Aug;82(2):473–483. doi: 10.1161/01.cir.82.2.473. [DOI] [PubMed] [Google Scholar]
  19. Eichhorn E. J., Heesch C. M., Barnett J. H., Alvarez L. G., Fass S. M., Grayburn P. A., Hatfield B. A., Marcoux L. G., Malloy C. R. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1994 Nov 1;24(5):1310–1320. doi: 10.1016/0735-1097(94)90114-7. [DOI] [PubMed] [Google Scholar]
  20. Elkayam U., Amin J., Mehra A., Vasquez J., Weber L., Rahimtoola S. H. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 1990 Dec;82(6):1954–1961. doi: 10.1161/01.cir.82.6.1954. [DOI] [PubMed] [Google Scholar]
  21. Engelmeier R. S., O'Connell J. B., Walsh R., Rad N., Scanlon P. J., Gunnar R. M. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. 1985 Sep;72(3):536–546. doi: 10.1161/01.cir.72.3.536. [DOI] [PubMed] [Google Scholar]
  22. Ferguson D. W., Berg W. J., Sanders J. S., Roach P. J., Kempf J. S., Kienzle M. G. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation. 1989 Jul;80(1):65–77. doi: 10.1161/01.cir.80.1.65. [DOI] [PubMed] [Google Scholar]
  23. Fonarow G. C., Chelimsky-Fallick C., Stevenson L. W., Luu M., Hamilton M. A., Moriguchi J. D., Tillisch J. H., Walden J. A., Albanese E. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol. 1992 Mar 15;19(4):842–850. doi: 10.1016/0735-1097(92)90529-v. [DOI] [PubMed] [Google Scholar]
  24. Franciosa J. A., Mikulic E., Cohn J. N., Jose E., Fabie A. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation. 1974 Nov;50(5):1020–1024. doi: 10.1161/01.cir.50.5.1020. [DOI] [PubMed] [Google Scholar]
  25. Franciosa J. A., Pierpont G., Cohn J. N. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Ann Intern Med. 1977 Apr;86(4):388–393. doi: 10.7326/0003-4819-86-4-388. [DOI] [PubMed] [Google Scholar]
  26. Guazzi M. D., Campodonico J., Celeste F., Guazzi M., Santambrogio G., Rossi M., Trabattoni D., Alimento M. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther. 1998 Jan;63(1):79–86. doi: 10.1016/S0009-9236(98)90123-0. [DOI] [PubMed] [Google Scholar]
  27. Guazzi M., Melzi G., Agostoni P. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997 Dec 15;80(12):1572–1576. doi: 10.1016/s0002-9149(97)00781-9. [DOI] [PubMed] [Google Scholar]
  28. Hall S. A., Cigarroa C. G., Marcoux L., Risser R. C., Grayburn P. A., Eichhorn E. J. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 1995 Apr;25(5):1154–1161. doi: 10.1016/0735-1097(94)00543-y. [DOI] [PubMed] [Google Scholar]
  29. Heilbrunn S. M., Shah P., Bristow M. R., Valantine H. A., Ginsburg R., Fowler M. B. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 1989 Mar;79(3):483–490. doi: 10.1161/01.cir.79.3.483. [DOI] [PubMed] [Google Scholar]
  30. Ho K. K., Pinsky J. L., Kannel W. B., Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):6A–13A. doi: 10.1016/0735-1097(93)90455-a. [DOI] [PubMed] [Google Scholar]
  31. Hobbs R. E., Miller L. W., Bott-Silverman C., James K. B., Rincon G., Grossbard E. B. Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1996 Oct 15;78(8):896–901. doi: 10.1016/s0002-9149(96)00464-x. [DOI] [PubMed] [Google Scholar]
  32. Ikram H., Chan W., Espiner E. A., Nicholls M. G. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci (Lond) 1980 Dec;59(6):443–449. doi: 10.1042/cs0590443. [DOI] [PubMed] [Google Scholar]
  33. Ikram H., Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet. 1981 Sep 5;2(8245):490–493. doi: 10.1016/s0140-6736(81)90881-3. [DOI] [PubMed] [Google Scholar]
  34. Israili Z. H., Hall W. D. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992 Aug 1;117(3):234–242. doi: 10.7326/0003-4819-117-3-234. [DOI] [PubMed] [Google Scholar]
  35. Ju H., Zhao S., Jassal D. S., Dixon I. M. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res. 1997 Aug;35(2):223–232. doi: 10.1016/s0008-6363(97)00130-2. [DOI] [PubMed] [Google Scholar]
  36. Koniaris L. S., Goldhaber S. Z. Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol. 1998 Mar 15;31(4):745–748. doi: 10.1016/s0735-1097(98)00003-5. [DOI] [PubMed] [Google Scholar]
  37. Levin E. R., Gardner D. G., Samson W. K. Natriuretic peptides. N Engl J Med. 1998 Jul 30;339(5):321–328. doi: 10.1056/NEJM199807303390507. [DOI] [PubMed] [Google Scholar]
  38. Levine T. B., Francis G. S., Goldsmith S. R., Simon A. B., Cohn J. N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982 May;49(7):1659–1666. doi: 10.1016/0002-9149(82)90243-0. [DOI] [PubMed] [Google Scholar]
  39. Loh E., Sutton M. S., Wun C. C., Rouleau J. L., Flaker G. C., Gottlieb S. S., Lamas G. A., Moyé L. A., Goldhaber S. Z., Pfeffer M. A. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997 Jan 23;336(4):251–257. doi: 10.1056/NEJM199701233360403. [DOI] [PubMed] [Google Scholar]
  40. Marcus L. S., Hart D., Packer M., Yushak M., Medina N., Danziger R. S., Heitjan D. F., Katz S. D. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation. 1996 Dec 15;94(12):3184–3189. doi: 10.1161/01.cir.94.12.3184. [DOI] [PubMed] [Google Scholar]
  41. McMurray J. J., Ray S. G., Abdullah I., Dargie H. J., Morton J. J. Plasma endothelin in chronic heart failure. Circulation. 1992 Apr;85(4):1374–1379. doi: 10.1161/01.cir.85.4.1374. [DOI] [PubMed] [Google Scholar]
  42. Milanez M. C., Gomes M. G., Vassallo D. V., Mill J. G. Effects of captopril on interstitial collagen in the myocardium after infarction in rats. J Card Fail. 1997 Sep;3(3):189–197. doi: 10.1016/s1071-9164(97)90015-4. [DOI] [PubMed] [Google Scholar]
  43. Miller W. L., Redfield M. M., Burnett J. C., Jr Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest. 1989 Jan;83(1):317–320. doi: 10.1172/JCI113876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Molina C. R., Fowler M. B., McCrory S., Peterson C., Myers B. D., Schroeder J. S., Murad F. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol. 1988 Jul;12(1):175–186. doi: 10.1016/0735-1097(88)90371-3. [DOI] [PubMed] [Google Scholar]
  45. Münzel T., Kurz S., Holtz J., Busse R., Steinhauer H., Just H., Drexler H. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation. 1992 Oct;86(4):1089–1098. doi: 10.1161/01.cir.86.4.1089. [DOI] [PubMed] [Google Scholar]
  46. Nguyen K. N., Aursnes I., Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) Am J Cardiol. 1997 Jan 15;79(2):115–119. doi: 10.1016/s0002-9149(96)00696-0. [DOI] [PubMed] [Google Scholar]
  47. Packer M., Bristow M. R., Cohn J. N., Colucci W. S., Fowler M. B., Gilbert E. M., Shusterman N. H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23;334(21):1349–1355. doi: 10.1056/NEJM199605233342101. [DOI] [PubMed] [Google Scholar]
  48. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  49. Packer M., Gheorghiade M., Young J. B., Costantini P. J., Adams K. F., Cody R. J., Smith L. K., Van Voorhees L., Gourley L. A., Jolly M. K. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med. 1993 Jul 1;329(1):1–7. doi: 10.1056/NEJM199307013290101. [DOI] [PubMed] [Google Scholar]
  50. Packer M., O'Connor C. M., Ghali J. K., Pressler M. L., Carson P. E., Belkin R. N., Miller A. B., Neuberg G. W., Frid D., Wertheimer J. H. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med. 1996 Oct 10;335(15):1107–1114. doi: 10.1056/NEJM199610103351504. [DOI] [PubMed] [Google Scholar]
  51. Parmley W. W. Cost-effective management of heart failure. Clin Cardiol. 1996 Mar;19(3):240–242. doi: 10.1002/clc.4960190319. [DOI] [PubMed] [Google Scholar]
  52. Pfeffer M. A., Stevenson L. W. Beta-adrenergic blockers and survival in heart failure. N Engl J Med. 1996 May 23;334(21):1396–1397. doi: 10.1056/NEJM199605233342109. [DOI] [PubMed] [Google Scholar]
  53. Pitt B., Segal R., Martinez F. A., Meurers G., Cowley A. J., Thomas I., Deedwania P. C., Ney D. E., Snavely D. B., Chang P. I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet. 1997 Mar 15;349(9054):747–752. doi: 10.1016/s0140-6736(97)01187-2. [DOI] [PubMed] [Google Scholar]
  54. Renard C., Grene-Lerouge N., Beau N., Baud F., Scherrmann J. M. Pharmacokinetics of digoxin-specific Fab: effects of decreased renal function and age. Br J Clin Pharmacol. 1997 Aug;44(2):135–138. doi: 10.1046/j.1365-2125.1997.00654.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Roald H. E., Barstad R. M., Kierulf P., Skjørten F., Dickinson J. P., Kieffer G., Sakariassen K. S. Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions. Thromb Haemost. 1994 May;71(5):655–662. [PubMed] [Google Scholar]
  56. Saito Y., Nakao K., Nishimura K., Sugawara A., Okumura K., Obata K., Sonoda R., Ban T., Yasue H., Imura H. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation. 1987 Jul;76(1):115–124. doi: 10.1161/01.cir.76.1.115. [DOI] [PubMed] [Google Scholar]
  57. Sedman A. B., Kershaw D. B., Bunchman T. E. Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Pediatr Nephrol. 1995 Jun;9(3):382–385. doi: 10.1007/BF02254221. [DOI] [PubMed] [Google Scholar]
  58. Spaulding C., Charbonnier B., Cohen-Solal A., Juillière Y., Kromer E. P., Benhamda K., Cador R., Weber S. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. Circulation. 1998 Aug 25;98(8):757–765. doi: 10.1161/01.cir.98.8.757. [DOI] [PubMed] [Google Scholar]
  59. Stoller J. K., Elghazawi A., Mehta A. C., Vidt D. G. Captopril-induced cough. Chest. 1988 Mar;93(3):659–661. doi: 10.1378/chest.93.3.659. [DOI] [PubMed] [Google Scholar]
  60. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet. 1979 Jun 30;1(8131):1374–1376. doi: 10.1016/s0140-6736(79)92010-5. [DOI] [PubMed] [Google Scholar]
  61. Taylor K., Patten R. D., Smith J. J., Aronovitz M. J., Wight J., Salomon R. N., Konstam M. A. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. J Cardiovasc Pharmacol. 1998 May;31(5):654–660. doi: 10.1097/00005344-199805000-00002. [DOI] [PubMed] [Google Scholar]
  62. Uretsky B. F., Young J. B., Shahidi F. E., Yellen L. G., Harrison M. C., Jolly M. K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct;22(4):955–962. doi: 10.1016/0735-1097(93)90403-n. [DOI] [PubMed] [Google Scholar]
  63. Waagstein F., Bristow M. R., Swedberg K., Camerini F., Fowler M. B., Silver M. A., Gilbert E. M., Johnson M. R., Goss F. G., Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993 Dec 11;342(8885):1441–1446. doi: 10.1016/0140-6736(93)92930-r. [DOI] [PubMed] [Google Scholar]
  64. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975 Oct;37(10):1022–1036. doi: 10.1136/hrt.37.10.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Watkins L., Jr, Burton J. A., Haber E., Cant J. R., Smith F. W., Barger A. C. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest. 1976 Jun;57(6):1606–1617. doi: 10.1172/JCI108431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Weber K. T., Brilla C. G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991 Jun;83(6):1849–1865. doi: 10.1161/01.cir.83.6.1849. [DOI] [PubMed] [Google Scholar]
  67. Williamson H. E., Bourland W. A., Marchand G. R. Inhibition of ethacrynic acid induced increase in renal blood flow by indomethacin. Prostaglandins. 1974 Nov 25;8(4):297–301. doi: 10.1016/s0090-6980(74)80094-8. [DOI] [PubMed] [Google Scholar]
  68. Wilson J. R., Reichek N., Dunkman W. B., Goldberg S. Effect of diuresis on the performance of the failing left ventricle in man. Am J Med. 1981 Feb;70(2):234–239. doi: 10.1016/0002-9343(81)90755-5. [DOI] [PubMed] [Google Scholar]
  69. Yoshimura M., Yasue H., Morita E., Sakaino N., Jougasaki M., Kurose M., Mukoyama M., Saito Y., Nakao K., Imura H. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991 Oct;84(4):1581–1588. doi: 10.1161/01.cir.84.4.1581. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES